Literature DB >> 23881025

Analysis of risk factors and survival in pediatric high-grade spinal cord astrocytoma: a population-based study.

Sandi Lam1, Yimo Lin, Stephanie Melkonian.   

Abstract

BACKGROUND/AIMS: Primary pediatric high-grade spinal cord astrocytomas are rare neoplasms with poor prognoses. Using the Surveillance, Epidemiology, and End Results (SEER) database, we analyzed prognostic factors and survival.
METHODS: Pediatric patients with histologically confirmed diagnoses of primary high-grade spinal cord astrocytoma (WHO grade III-IV) from 1973 to 2008 in the SEER database were studied. Univariate and multivariate Cox proportional hazards models were used to analyze the relationship between demographic, tumor grade, and treatment factors on survival.
RESULTS: Median survival in the 48 patient cohort was 10 months. Increasing age and higher tumor grade were found to be significantly associated with higher mortality. For children aged <7, 7-12, and 13-18 years, median survival was 22, 11, and 8 months, respectively. For children with anaplastic astrocytoma (WHO grade III), median survival was 12 months, compared with 7 months for those with glioblastoma multiforme (WHO grade IV). This study did not find a statistically significant relationship between sex, race, presence of radiation therapy or extent of surgical resection and mortality.
CONCLUSION: Survival in primary pediatric high-grade spinal cord astrocytomas was positively associated with younger age and lower tumor grade. Survival was not associated with other demographic or treatment modality factors.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23881025     DOI: 10.1159/000353135

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  9 in total

Review 1.  Adult pilocytic astrocytoma of conus medullaris: clinical considerations and review of the literature.

Authors:  José Pedro Lavrador; Edson Oliveira; José Pimentel; Sérgio Livraghi
Journal:  CNS Oncol       Date:  2017-04

Review 2.  Primary and metastatic glioblastoma of the spine in the pediatric population: a systematic review.

Authors:  Runze Yang; Albert M Isaacs; Magalie Cadieux; Tomas J Hirmer; Travis S CreveCoeur; Andrew P Lapointe; Michael Opoku-Darko; Zahra Premji; Jay Riva-Cambrin; Clare N Gallagher
Journal:  Childs Nerv Syst       Date:  2021-03-06       Impact factor: 1.475

3.  Pediatric neuro-oncology survival disparities in California.

Authors:  Tabitha Cooney; Paul G Fisher; Li Tao; Christina A Clarke; Sonia Partap
Journal:  J Neurooncol       Date:  2018-02-07       Impact factor: 4.130

4.  Pediatric primary high-grade spinal glioma: a National Cancer Database analysis of current patterns in treatment and outcomes.

Authors:  Ravi S Nunna; Syed Khalid; Mandana Behbahani; Ankit I Mehta
Journal:  Childs Nerv Syst       Date:  2020-06-12       Impact factor: 1.475

5.  Primary spinal glioblastoma multiforme: A case report and review of the literature.

Authors:  Chao-Xiong Shen; Jian-Feng Wu; Wei Zhao; Zhao-Wen Cai; Ran-Ze Cai; Chun-Mei Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Glioblastoma multiforme in conus medullaris with intracranial metastasis after postoperative adjuvant therapy.

Authors:  Chengrui Yan; Xiangyi Kong; Hua Yin; Yu Wang; Huayu He; Hui Zhang; Jun Gao; Yongning Li; Wenbin Ma
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.

Authors:  Wenming Wang
Journal:  Biosci Rep       Date:  2019-06-14       Impact factor: 3.840

8.  Multifocal spinal glioblastoma and leptomeningeal carcinomatosis in an elderly male with hydrocephalus and myelopathy.

Authors:  George W Koutsouras; Annelle Amsellem; Timothy Richardson; Harish Babu
Journal:  Surg Neurol Int       Date:  2021-12-08

9.  Clinical outcomes and a therapeutic indication of intramedullary spinal cord astrocytoma.

Authors:  Narihito Nagoshi; Osahiko Tsuji; Satoshi Suzuki; Satoshi Nori; Mitsuru Yagi; Eijiro Okada; Hajime Okita; Nobuyuki Fujita; Ken Ishii; Morio Matsumoto; Masaya Nakamura; Kota Watanabe
Journal:  Spinal Cord       Date:  2021-07-26       Impact factor: 2.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.